A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with (18)F-DCFPyL in Prostate Cancer Patients (OSPREY)

PURPOSE: Prostate specific membrane antigen-targeted positron emission tomography/computerized tomography has the potential to improve the detection and localization of prostate cancer. OSPREY was a prospective trial designed to determine the diagnostic performance of (18)F-DCFPyL-positron emission...

Descripción completa

Detalles Bibliográficos
Autores principales: Pienta, Kenneth J., Gorin, Michael A., Rowe, Steven P., Carroll, Peter R., Pouliot, Frédéric, Probst, Stephan, Saperstein, Lawrence, Preston, Mark A., Alva, Ajjai S., Patnaik, Akash, Durack, Jeremy C., Stambler, Nancy, Lin, Tess, Jensen, Jessica, Wong, Vivien, Siegel, Barry A., Morris, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556578/
https://www.ncbi.nlm.nih.gov/pubmed/33634707
http://dx.doi.org/10.1097/JU.0000000000001698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556578/
https://www.ncbi.nlm.nih.gov/pubmed/33634707
http://dx.doi.org/10.1097/JU.0000000000001698

Ejemplares similares